Clinical Sepsis Phenotypes in Critically Ill COVID-19 Patients

Decorative image of the COVID-19 Learning Lounge

Clinical Sepsis Phenotypes in Critically Ill COVID-19 Patients

SUMMARY

Researchers compared the phenotypic distribution of clinical sepsis traits between sepsis patients, both with and without COVID-19. Because COVID-19 can fulfill the sepsis criteria in some cases, examining phenotypes derived from sepsis patients may aid in predicting patient outcomes, treatment efficacy, and personalized medicine.

FEATURED EXPERT

University of Amsterdam, Department of Intensive Care Medicine, University of Pittsburgh School of Medicine, Department of Critical Care Medicine

GET STARTED

Access the study at BioMed Central.

Take me there now!

Read time: 10 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

Take Our Poll

Global Solutions

VIDAS^®B•R•A•H•M•S PCT™

Detects procalcitonin, a biomarker that aids in the risk assessment for progression to severe sepsis and septic shock. PCT also aids in decision making on antibiotic therapy for patients with lower respiratory tract infections (LRTI).

Learn More